Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Treatment of sepsis and septic shock

A technology for septic shock and sepsis, applied in the field of septic shock, sepsis, acute respiratory distress syndrome and severe sepsis, can solve neurological and cognitive sequelae and other problems, and achieve improvement of clinical signs and symptoms, Reasonable efficacy and improved hemodynamic parameters

Pending Publication Date: 2020-11-20
COMBIOXIN SA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, chronic tissue hypoperfusion may lead to long-term neurological and cognitive sequelae

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment of sepsis and septic shock
  • Treatment of sepsis and septic shock
  • Treatment of sepsis and septic shock

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0141] Treatment of sepsis and septic shock in severely infected patients

[0142] In a subsequently reported study, a highly preferred mixture of empty liposomes of the present invention (designated CAL02) was administered intravenously (IV) as an adjunct to standard antibiotic therapy in severe Patients admitted to the intensive care unit (ICU) with community-acquired pneumonia (CAP). Said highly preferred inventive mixture of empty liposomes (CAL02) consists of a 1:1 (weight / weight-w / w) mixture of said first empty liposomes and said second liposomes, wherein The first empty liposome was composed of sphingomyelin and cholesterol in a 1:1 weight ratio (1:1 w / w; molar ratio 35:65), and the second empty liposome was composed of sphingomyelin only.

[0143] In addition to standard-of-care antibiotic therapy (Mandel et al., CID 2007:44(Suppl 2), S27-S72), each patient received two infusions of CAL02 or placebo (physiological 0.9% NaCl solution) with intervals of 24 hours or 48 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention relates to a composition comprising a mixture of empty liposomes, wherein said mixture of empty liposomes comprises (a) a first empty liposome comprising cholesterol, wherein theamount of cholesterol is at least 30% (weight per weight); and (b) a second empty liposome comprising sphingomyelin, for use in the treatment of sepsis, severe sepsis, septic shock, or prolonged andsevere hypotension, preferably persistent hypotension, for use in the treatment of hypotension, preferably said persistent hypotension, in septic shock, sepsis, severe sepsis, acute respiratory distress syndrome or acute lung injury, or for use in the treatment of toxic shock syndrome in an animal, preferably in a human.

Description

[0001] The present invention relates to a composition comprising a mixture of empty liposomes, wherein the mixture of empty liposomes comprises: (a) a first empty liposome comprising cholesterol, wherein the amount of cholesterol is at least 30% (weight / weight); and (b) a second empty liposome comprising sphingomyelin, said composition being used to treat sepsis, severe sepsis, septic shock or chronic and severe hypotension in an animal, preferably a human , preferably persistent hypotension, for the treatment of hypotension, preferably persistent hypotension, in animals, preferably humans, in septic shock, sepsis, severe sepsis, acute respiratory distress syndrome or acute lung injury, or for Toxic shock syndrome in animals, preferably humans, is treated. In particular, the present invention relates to compositions for use in the treatment of sepsis or septic shock in animals, preferably humans. Background technique [0002] Sepsis is a potentially life-threatening organ dys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/28A61K9/127A61K31/575A61K31/688A61P31/00
CPCA61K9/127A61K31/575A61K31/688A61K47/28A61P31/00A61K9/0019Y02A50/30A61K2300/00
Inventor S·阿泽雷多·达·西尔维拉·拉雅尤尼亚斯F·拉雅尤尼亚斯
Owner COMBIOXIN SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com